Federated Hermes’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5K | Buy |
6,613
+1,483
| +29% | +$3.02K | ﹤0.01% | 1771 |
|
|
2025
Q1 | $8.36K | Buy |
5,130
+3,517
| +218% | +$5.73K | ﹤0.01% | 1832 |
|
|
2024
Q4 | $2.95K | Buy |
+1,613
| New | +$2.95K | ﹤0.01% | 1944 |
|
|
2023
Q2 | – | Sell |
-261
| Closed | -$2.56K | – | 2166 |
|
|
2023
Q1 | $2.56K | Buy |
261
+151
| +137% | +$1.48K | ﹤0.01% | 1988 |
|
|
2022
Q4 | $2.05K | Sell |
110
-53
| -33% | -$988 | ﹤0.01% | 2002 |
|
|
2022
Q3 | $4K | Sell |
163
-43
| -21% | -$1.06K | ﹤0.01% | 1910 |
|
|
2022
Q2 | $4K | Buy |
206
+158
| +329% | +$3.07K | ﹤0.01% | 1910 |
|
|
2022
Q1 | $2K | Buy |
+48
| New | +$2K | ﹤0.01% | 2026 |
|
|
2020
Q4 | – | Sell |
-2
| Closed | -$1K | – | 2276 |
|
|
2020
Q3 | $1K | Sell |
2
-8,139
| -100% | -$4.07M | ﹤0.01% | 2160 |
|
|
2020
Q2 | $2.63M | Buy |
8,141
+8,123
| +45,128% | +$2.63M | 0.01% | 893 |
|
|
2020
Q1 | $2K | Buy |
+18
| New | +$2K | ﹤0.01% | 2017 |
|
|
2019
Q4 | – | Sell |
-65
| Closed | -$2K | – | 2257 |
|
|
2019
Q3 | $2K | Sell |
65
-282
| -81% | -$8.68K | ﹤0.01% | 2029 |
|
|
2019
Q2 | $12K | Hold |
347
| – | – | ﹤0.01% | 1876 |
|
|
2019
Q1 | $16K | Sell |
347
-8,811
| -96% | -$406K | ﹤0.01% | 1807 |
|
|
2018
Q4 | $440K | Buy |
9,158
+9,024
| +6,734% | +$434K | ﹤0.01% | 1461 |
|
|
2018
Q3 | $9K | Buy |
+134
| New | +$9K | ﹤0.01% | 1969 |
|
|
2018
Q1 | – | Sell |
-153
| Closed | -$8K | – | 2189 |
|
|
2017
Q4 | $8K | Sell |
153
-4
| -3% | -$209 | ﹤0.01% | 1918 |
|
|
2017
Q3 | $12K | Buy |
+157
| New | +$12K | ﹤0.01% | 1815 |
|